Latest / Ageless and Timeless Podcast® / Adam Perlman, internationally recognized expert in Integrative and Functional Medicine
Transcript
- 0:10Speaker 1: Good morning everyone. This is Michelle Hughes from Ageless and Timeless.
- 0:14Speaker 1: Today I have doctor Adam Perlman as my guest, and
- 0:18Speaker 1: I love the fact that I've been able to meet
- 0:20Speaker 1: doctor Perlman or Adam. I'm going to call him if
- 0:24Speaker 1: he doesn't mind, but I'm going to just say that.
- 0:29Speaker 1: You know, very often I have guests on that I've
- 0:31Speaker 1: never met, but i've you know, we talk on the phone.
- 0:34Speaker 1: But with doctor Perlman, he because the company he's with,
- 0:38Speaker 1: which is called Pendulum Therapeutics, is based in San Francisco,
- 0:43Speaker 1: although he is resides in Jacksonville, Florida, but he comes
- 0:48Speaker 1: here frequently, so we were able to actually meet in person.
- 0:52Speaker 1: Had a lovely dinner and good morning or good afternoon
- 0:56Speaker 1: for you, doctor Perlman or Adam, see you again, so
- 1:01Speaker 1: happy to have you. Yeah, we had a really healthy
- 1:03Speaker 1: dinner at although I have to admit I noticed that
- 1:07Speaker 1: he can cheat a little bit, but that's okay. Look
- 1:09Speaker 1: at look at how good he looks. And I know,
- 1:14Speaker 1: but we both come from Massachusetts, from Boston area, and
- 1:18Speaker 1: although you know, neither one of us is living there now,
- 1:21Speaker 1: we both know that that's our base, our home. Routes
- 1:24Speaker 1: and fortunately for both of us, we don't have Boston accents,
- 1:28Speaker 1: right Adam.
- 1:29Speaker 2: Only when I go to park my car at a party. Yeah,
- 1:32Speaker 2: otherwise I.
- 1:34Speaker 1: Always people have said to me every you know, I
- 1:36Speaker 1: don't drink very much, but every once in a while,
- 1:38Speaker 1: if I have a glass of wine or something, that's
- 1:40Speaker 1: when it will come back. So I guess it's still
- 1:44Speaker 1: in our DNA. But fortunately we've been away long enough.
- 1:49Speaker 1: Even though you go back for your summers and I
- 1:52Speaker 1: often go back for family, but at least we sound
- 1:56Speaker 1: like we're from other parts of the world of the country. Well, anyway,
- 2:01Speaker 1: I'm so happy to have you. Let me tell everybody
- 2:04Speaker 1: who you are, and then I'm going to let you
- 2:05Speaker 1: take over. So I just want to say about Adam
- 2:10Speaker 1: that he is he is way ahead of his time.
- 2:13Speaker 1: And I say that because, you know, he worked at
- 2:18Speaker 1: both the Mayo Clinic and Duke and he actually worked
- 2:21Speaker 1: in New Jersey for a little bit. It was was
- 2:22Speaker 1: called Health Systems, the company in New Jersey.
- 2:26Speaker 2: And oh well I was at I was at Saint
- 2:29Speaker 2: Barnabas that health system and then move most of my
- 2:32Speaker 2: time over to what was u M D NJ. It's
- 2:35Speaker 2: now Rutgers so I kind of spent my time in
- 2:38Speaker 2: New Jersey before I went to Duke in twenty eleven, right, and.
- 2:41Speaker 1: He has he has all his degrees from from Tufts
- 2:46Speaker 1: and from Boston University, so that is consistent with where
- 2:50Speaker 1: he grew up. But anyway, he when I say, he's
- 2:55Speaker 1: ahead of his time. So he started early on in
- 2:58Speaker 1: at Rutgers, as he said, then he went to the
- 3:00Speaker 1: Mayo Clinic and they went did you go to Mayo
- 3:03Speaker 1: Clinic first and then.
- 3:04Speaker 2: Duke Duke first?
- 3:06Speaker 1: Yes, Duke, So he was in Duke and then the
- 3:08Speaker 1: Mayo Clinic and both all three of those places. He
- 3:12Speaker 1: was a big way ahead of his time because he
- 3:15Speaker 1: was working in functional and integrative medicine way before they
- 3:20Speaker 1: became the kind of mainstream that they are today. So
- 3:24Speaker 1: what was it, Adam, that got you so aware of
- 3:29Speaker 1: and interested in focusing on an area of medicine that
- 3:33Speaker 1: you certainly were not studying in the early days of
- 3:39Speaker 1: your education of your medical education. So what was it
- 3:44Speaker 1: that led you to become an integrative medicine doctor?
- 3:49Speaker 2: Sure happy to answer that, and again, it's it's great
- 3:50Speaker 2: to be here with you doing this this podcast. Well,
- 3:55Speaker 2: I mean I did go to medical school, knowing I
- 3:57Speaker 2: had an interest in what at the time was referred
- 4:00Speaker 2: to as complementary and alternative medicine. Integrative didn't really exist
- 4:04Speaker 2: as a term, nor did functional medicine back then, and
- 4:08Speaker 2: I was intrigued. I mean, again, without going way back
- 4:12Speaker 2: into my history, I mean, I had a background in
- 4:14Speaker 2: martial arts, but I was intrigued in things that came
- 4:18Speaker 2: from other healing traditions. But I really was interested in
- 4:21Speaker 2: trying to be a part of a small part of
- 4:23Speaker 2: a transformation of healthcare because I wondered why we didn't
- 4:26Speaker 2: integrate more of this into the conventional system. At that time.
- 4:29Speaker 2: It was things like acupuncture, certainly, vitamins, dietary supplements, probiotics,
- 4:34Speaker 2: massage therapy, and really wanted to look at the evidence
- 4:37Speaker 2: for these sorts of interventions. I thought it was really
- 4:40Speaker 2: important that we do that and contribute to that evidence.
- 4:42Speaker 2: So I've had along with my clinical career, I've done
- 4:46Speaker 2: a fair amount of research throughout my career. So even
- 4:49Speaker 2: going to medical school, knew it was an interest. Had
- 4:52Speaker 2: a phenomenal opportunity right after finishing my training to start
- 4:56Speaker 2: one of the earlier hospital based integrative medicine programs Healthcare
- 5:00Speaker 2: system in New Jersey, as you've just mentioned in the intro,
- 5:04Speaker 2: and really enjoyed that. In twenty eleven, again phenomenal opportunity
- 5:09Speaker 2: to go to Duke where I did run Duke Integrative Medicine.
- 5:12Speaker 2: They have a beautiful program there, also oversaw the Duke
- 5:15Speaker 2: Diet Center and a fitness center, and that was when
- 5:20Speaker 2: I would say, you know, around that time period twenty
- 5:24Speaker 2: ten twenty eleven, I began more formal functional medicine training
- 5:29Speaker 2: and that really launched my interest in gut health and
- 5:33Speaker 2: its connection to chronic diseases. Began to implement a lot
- 5:37Speaker 2: of that sort of an approach, sort of focusing on
- 5:40Speaker 2: the gut very often for various chronic diseases while I
- 5:45Speaker 2: was at Duke, and then as you've mentioned, I was
- 5:48Speaker 2: recruited to Mayo Clinic in Jacksonville, Florida that was two
- 5:52Speaker 2: thousand and nineteen to build their integrative functional medicine program. Again,
- 5:58Speaker 2: really enjoyed what I was doing there. I believe it
- 6:02Speaker 2: was there that I gave a talk on what it's
- 6:06Speaker 2: called Grand Rounds talk, which I could talk for your
- 6:08Speaker 2: colleagues within the medical center on the connection between gut
- 6:12Speaker 2: health and chronic diseases. And I also gave a talk
- 6:15Speaker 2: at a Mayo Nutrition conference, and I think maybe that's
- 6:17Speaker 2: where Colleen Cutcliffe, our CEO at Pendulum, saw me. Mayo
- 6:22Speaker 2: Ventures was an early investor in Pendulum, and so she
- 6:25Speaker 2: reached out to do a study for Pendulum, a repeat, larger,
- 6:30Speaker 2: mo robust study on one of their products called Pendulum
- 6:32Speaker 2: Glucose Control. So this was a study on Type two diabetics.
- 6:36Speaker 2: And in designing that study and using their products on
- 6:40Speaker 2: my patients, you know, I really appreciated, certainly the efficacy
- 6:45Speaker 2: of the products in my clinical practice, but the commitment
- 6:47Speaker 2: of the company to the science and what have you.
- 6:49Speaker 2: And still wasn't thinking of leaving Mayo. But when the
- 6:53Speaker 2: chief medical officer decided to retire, it just was a
- 6:56Speaker 2: phenomenal opportunity. So as of the beginning of twenty twenty four,
- 7:02Speaker 2: I jumped ship, so to speak, and have been chief
- 7:05Speaker 2: medical officer at Pendulum since that time.
- 7:08Speaker 1: You know, it's really interesting too, because you were in
- 7:12Speaker 1: the actually the bureaucratic, bigger organizations, So now you're in
- 7:17Speaker 1: an entrepreneurial not exactly a startup anymore, but it's still
- 7:22Speaker 1: an early stage company. What have you found to be
- 7:25Speaker 1: the differences in your working environment, your ability to get
- 7:30Speaker 1: things done, your interaction with your staff and all that.
- 7:35Speaker 1: How would you describe the difference between the big company
- 7:39Speaker 1: and the small companies that you're in now?
- 7:43Speaker 2: I mean, again a great question. I have spent I mean,
- 7:46Speaker 2: pretty much the majority obviously of my twenty six now
- 7:50Speaker 2: year career, since I finished my training primarily within large
- 7:55Speaker 2: academic health center systems like Duke and like Mayo Clinic,
- 8:00Speaker 2: and I enjoyed that, and I feel to a certain
- 8:02Speaker 2: degree I learned to be successful obviously in those environments.
- 8:05Speaker 2: But it does take some persistence. It takes you need
- 8:11Speaker 2: to be patient, and when you're trying to do innovative things,
- 8:15Speaker 2: and of course when you're building integrative medicine programs in
- 8:19Speaker 2: a way, by definition you're trying to be innovative within
- 8:21Speaker 2: the conventional system. You know, it takes time, without a doubt,
- 8:27Speaker 2: And there are things that I can get done in
- 8:30Speaker 2: you know, three days perhaps if not three minutes at
- 8:34Speaker 2: Pendulum that might take me three months or longer at
- 8:39Speaker 2: somewhere like Mayo Clinic. Again, was very proud and very
- 8:42Speaker 2: proud that I was at Mayo and that I've had
- 8:44Speaker 2: opportunites to be at Duke, but it has been a
- 8:46Speaker 2: very different experience to be able to move a little
- 8:49Speaker 2: more quickly, be a little more nimble, and bring ideas
- 8:53Speaker 2: to fruition and still be on this sort of cutting edge.
- 8:56Speaker 2: I mean it mayo obviously I felt because while but
- 8:58Speaker 2: I felt like we were providing certainly cutting edge conventional care.
- 9:02Speaker 2: But at Pendulum we are really sort of at the
- 9:05Speaker 2: at the forefront of leading kind of this next great
- 9:08Speaker 2: frontier of health care and our understanding of health and
- 9:13Speaker 2: as it relates to the development of diseases, which is
- 9:15Speaker 2: really looking at the microbiome, looking at these next generation
- 9:19Speaker 2: probiotics and how we can use them to really bring
- 9:22Speaker 2: about a new sort of health reality for people that
- 9:26Speaker 2: just couldn't achieve the goals their health related goals, you know,
- 9:29Speaker 2: in the past. So that's been very exciting for me.
- 9:31Speaker 1: And have you given up seeing patients? Thank you?
- 9:36Speaker 2: Yeah, No, I didn't want to totally give that up.
- 9:39Speaker 2: I mean, I love seeing patients and I love providing
- 9:42Speaker 2: integrate of functional medicine, and so I do have a
- 9:46Speaker 2: very limited Obviously, I'm very busy with my role at Pendulum,
- 9:49Speaker 2: and I think one of the advantages is the company
- 9:51Speaker 2: is on the west coast and I'm on the on
- 9:53Speaker 2: the East coast. So a couple of mornings a week
- 9:56Speaker 2: I do see patients. I a couple of patients this morning,
- 10:00Speaker 2: and you know, that's been great to be able to
- 10:02Speaker 2: keep my hand in it. I have a practice in
- 10:04Speaker 2: Jacksonville that has allowed me to do that.
- 10:08Speaker 1: And have you stayed as a specialist? Now are you
- 10:11Speaker 1: continuing to just say patients see you are referred to
- 10:15Speaker 1: you as a now a functional medicine doctor with a
- 10:19Speaker 1: microbio expertise.
- 10:22Speaker 2: I mean, yes, that's always what I've done. So, I
- 10:25Speaker 2: mean I trained as an intern is certainly trained in
- 10:27Speaker 2: primary care. But just given the nature of my career,
- 10:30Speaker 2: I haven't practiced as a primary care physician. I've practiced
- 10:36Speaker 2: primarily as an integrative functional medicine physician sort of consultant,
- 10:41Speaker 2: and that's worked out well. But I see all kinds
- 10:44Speaker 2: of things that one might imagine that we see in
- 10:47Speaker 2: these sorts of practice. Certainly cancer as a part of it,
- 10:49Speaker 2: chronic pain, autoimmune conditions, a lot of gut related issues,
- 10:53Speaker 2: and in functional medicine, as you're aware, and with integrative
- 10:57Speaker 2: I mean we're interested in trying to get it root
- 10:58Speaker 2: cause A certainly this integration of complementary modalities, But what
- 11:03Speaker 2: I really like about the approach clinically is it's really
- 11:06Speaker 2: thinking about issues from the perspective of the biological systems
- 11:10Speaker 2: and how can we correct those systems, and how might
- 11:13Speaker 2: those biological systems may be influencing the disease or the
- 11:16Speaker 2: symptom that the patient is presenting with. And that's why
- 11:19Speaker 2: so much of the focus goes on the gut, because
- 11:21Speaker 2: the gut is so pivotal to so many diseases and
- 11:26Speaker 2: symptoms that patients may be experiencing, from joint pain to
- 11:31Speaker 2: gut related issues to headaches, there may be a gut
- 11:33Speaker 2: related component to that to the condition.
- 11:37Speaker 1: European Wellness, founded by the iconic and widely published professor
- 11:41Speaker 1: doctor Michael Chan, is the world leader in stem cell
- 11:45Speaker 1: and peptide therapy, with twenty six medical and aesthetics SPA
- 11:49Speaker 1: locations primarily in Europe and Asia. Their website www dot
- 11:55Speaker 1: Europeanwellness dot com details the wide range of wellness products
- 12:00Speaker 1: can be ordered using the age's code for a ten
- 12:03Speaker 1: percent discount. They will also offer our viewers discounts on
- 12:07Speaker 1: medical and cosmetic services and products that they choose to
- 12:10Speaker 1: visit the clinics. I have firsthand experience using their wide
- 12:14Speaker 1: range of science based stem cell and peptide products and
- 12:18Speaker 1: are now a loyal customer. Go to their website www.
- 12:23Speaker 1: Europeanwellness dot com for more information about this exciting company.
- 12:30Speaker 1: You know, it's so interesting though, because the microbiome has
- 12:34Speaker 1: really only become the darling of the functional medicine industry
- 12:38Speaker 1: or a profession, let's say, in the last few years.
- 12:42Speaker 1: I mean, nobody really paid that much attention and the
- 12:45Speaker 1: gut brain access and the microbiome as the key to
- 12:49Speaker 1: longevity and health span and so forth. So you, again,
- 12:54Speaker 1: as I said, you were ahead of your time, and
- 12:57Speaker 1: I think you know as a in the forefront of
- 13:01Speaker 1: the expertise. Is there anything that you can say you
- 13:06Speaker 1: learned in the beginning that you would say was incorrect
- 13:10Speaker 1: and would not be what you would use today in
- 13:13Speaker 1: terms of the knowledge of the microbiome and how it
- 13:16Speaker 1: functions in promoting our longevity.
- 13:20Speaker 2: Well, let me make a first a comment even before
- 13:23Speaker 2: I answer your question directly, because you just noted that
- 13:29Speaker 2: we've sort of had this explosion of interest in the
- 13:32Speaker 2: microbiome and part of what has allowed that to occur,
- 13:36Speaker 2: or has sort of been the impetus for that, is
- 13:38Speaker 2: that the technology to study the microbiome has really advanced
- 13:43Speaker 2: over the last twenty plus years, you know, whereas we
- 13:47Speaker 2: now have technologies beyond having to grow bacteria in some
- 13:52Speaker 2: petri dish like you did in you know, maybe high
- 13:55Speaker 2: school biology, to these genome sequencing technologies what's called something
- 14:00Speaker 2: called PCR, and that's really allowed us to study the
- 14:02Speaker 2: microbiome in a more detailed way, to study strains of bacteria,
- 14:07Speaker 2: for example, that are anaerobic that cannot be exposed to oxygen,
- 14:12Speaker 2: so you couldn't just kind of put them on a
- 14:14Speaker 2: petri dish in your lab. And that's where the discovery
- 14:17Speaker 2: of some of these really next generation keystone strains that
- 14:20Speaker 2: I know we're going to discuss. And this is part
- 14:22Speaker 2: of what Pendulum sort of claim to fame, is bringing
- 14:25Speaker 2: these strains to the marketplace. So that's what's allowed us.
- 14:28Speaker 2: And even every day, I mean, I you know, keep
- 14:31Speaker 2: up with the literature. It's like every day there's some
- 14:34Speaker 2: new study or other or multiple studies coming out that
- 14:37Speaker 2: is helping us to understand you know, yet another connection
- 14:41Speaker 2: of the gut microbiome to some sort of chronic disease
- 14:45Speaker 2: or disease development or health related issue. And so that's
- 14:49Speaker 2: been really exciting. I don't your question around, you know,
- 14:53Speaker 2: is there something that maybe I used to think that
- 14:57Speaker 2: I have changed. I guess I would answer that by saying,
- 15:02Speaker 2: you know, maybe even just four or five years ago,
- 15:04Speaker 2: if you said to me as a patient, let's say,
- 15:07Speaker 2: or you know, as a friend, should I take a colleague,
- 15:10Speaker 2: should I take a probiotic? You know, I might say, well,
- 15:14Speaker 2: I don't know, I'm not sure if you know, the
- 15:15Speaker 2: evidence is there for just taking a daily probiotic. But
- 15:18Speaker 2: if I think a lot of us used to just say,
- 15:21Speaker 2: you know, take something with at least five strains and
- 15:24Speaker 2: you know, thirty billion units. And I don't even know
- 15:27Speaker 2: where that came from exactly. I mean from colleagues. They've
- 15:30Speaker 2: heard it from me. And you know, those probiotics that
- 15:34Speaker 2: historically have been on the shelves have been Lactobacillis strains,
- 15:38Speaker 2: but fido Bacterium strains, things that I'm sure some of
- 15:41Speaker 2: your audience are familiar with, or if they, you know,
- 15:43Speaker 2: looked at the labels on their probiotics, and certainly they
- 15:47Speaker 2: have a role in the body. But you know, I
- 15:50Speaker 2: think what we've come to understand now is that if
- 15:54Speaker 2: you ask the question should I take a probiotic, then
- 15:58Speaker 2: I really need to ask the question what are you
- 16:00Speaker 2: taking it for? And what strain therefore are you taking
- 16:05Speaker 2: and what is the evidence for that particular strain for
- 16:07Speaker 2: that particular indication. And so we're not fully there yet.
- 16:11Speaker 2: We have a lot more to understand, but this idea
- 16:13Speaker 2: to be more precise and have more sort of precision
- 16:16Speaker 2: probiotics and know this strain has the best evidence for
- 16:21Speaker 2: your particular condition. That's really where I think the field
- 16:25Speaker 2: is moving as it relates to the whole concept of probiotics.
- 16:28Speaker 1: How many strains are there if you had to make
- 16:32Speaker 1: a lift.
- 16:34Speaker 2: Well, I mean, I think again this gets debated. People
- 16:37Speaker 2: tend to say anywhere from seventy to one hundred trillion
- 16:40Speaker 2: bacteria in the gud. There are hundreds to thousands of strains.
- 16:44Speaker 2: I mean, undoubtedly we probably haven't characterized all the strains,
- 16:47Speaker 2: but suffice it to say that it's a lot of
- 16:49Speaker 2: different a lot of bacteria and a lot of different
- 16:51Speaker 2: types of bacteria.
- 16:53Speaker 1: So a lot to ask a patient in terms of
- 16:57Speaker 1: and they may not even know the answers you know
- 16:59Speaker 1: that to give you because they don't know. Really, why
- 17:02Speaker 1: do I feel so badly? I just can't pinpoint what
- 17:06Speaker 1: it is? You know you are you are really a
- 17:08Speaker 1: detective when you're dealing with trying to discover the root
- 17:12Speaker 1: cause of the patient's symptoms, So right, I mean.
- 17:17Speaker 2: I think, and I think it even goes beyond. I mean,
- 17:20Speaker 2: I wouldn't call this necessarily a symptom, so it's it's symptoms,
- 17:23Speaker 2: but it's things like I can't control my cravings. Yes,
- 17:26Speaker 2: I'm not sure why that is. And and these things
- 17:29Speaker 2: were laid back directly, very often to the microbiome. And
- 17:32Speaker 2: this is a new insight that we've gained just over
- 17:36Speaker 2: the last few years.
- 17:38Speaker 1: Did you ever feel like you were just so at
- 17:43Speaker 1: a brick wall? I mean that you just couldn't figure
- 17:46Speaker 1: out what the answers were and you were just ready
- 17:49Speaker 1: to give up with with with limited the limited knowledge
- 17:54Speaker 1: of what you had back then compared to what you
- 17:57Speaker 1: might have been doing with the same patient today. Did
- 18:01Speaker 1: you ever feel like just hitting a brick wall?
- 18:05Speaker 2: Actually, I don't think I ever did, to be honest
- 18:07Speaker 2: with you. I mean, I think there's certainly, and having
- 18:11Speaker 2: practice at places like Duke and Mayo, and often very
- 18:15Speaker 2: often the majority of the time seeing patients that have
- 18:17Speaker 2: seen a number of other very bright healthcare providers and
- 18:22Speaker 2: haven't gotten the answers that they've wanted. And I'm in
- 18:25Speaker 2: no way implying I'm brighter than those other healthcare providers,
- 18:27Speaker 2: but taking a different approach, taking a different perspective on
- 18:30Speaker 2: the condition has often been helpful. But even when I
- 18:33Speaker 2: couldn't get to root cause, I've always kept it in
- 18:36Speaker 2: the back of my mind that there's always an opportunity
- 18:39Speaker 2: to try and relieve suffering. So even when we can't cure,
- 18:43Speaker 2: even when there's going to be some degree of ongoing
- 18:46Speaker 2: chronic symptoms or whatever the case may be, which is
- 18:51Speaker 2: the case more often than I wish, there's almost always
- 18:56Speaker 2: the opportunity to focus on relieving suffering in some way. So,
- 19:00Speaker 2: you know, that's that's something I was keeping the back
- 19:02Speaker 2: of my mind, you know, no matter who the patient
- 19:05Speaker 2: is that I'm seeing or what the issue may be
- 19:07Speaker 2: that I'm trying to address to Adam.
- 19:09Speaker 1: Until recently, probiotics were always kind of an enigma because
- 19:15Speaker 1: many of them you were just wasting your money you
- 19:17Speaker 1: couldn't spend the money to get the probiotics, but they
- 19:21Speaker 1: would never survive the digestive tract, the acidity. So how
- 19:27Speaker 1: is Pendulum different than these traditions. I know you're not
- 19:31Speaker 1: a probiotic company, You're a microbiome scientifically based company. So
- 19:36Speaker 1: I want to be clear with our audience that we're
- 19:38Speaker 1: not talking about just another probiotic. We're talking about eons
- 19:42Speaker 1: of knowledge and science beyond that, but going back to
- 19:47Speaker 1: the roots of probiotics where they just wouldn't survive. And
- 19:52Speaker 1: I can remember so many times buying a probiotic and
- 19:55Speaker 1: thinking it was doing me good and then reading that
- 19:58Speaker 1: the science behind it that that now I couldn't even
- 20:00Speaker 1: get through my digestive track. So how does Pendulum change
- 20:05Speaker 1: that and make the efficacy of the products get through
- 20:12Speaker 1: and not only the acidity, but slow methylaters or people
- 20:16Speaker 1: who are toxic and are not absorbing. How do you
- 20:19Speaker 1: get around all of that to make them work again?
- 20:23Speaker 2: A great question. I think it's probably best to answer
- 20:25Speaker 2: it by starting off with a little bit of the
- 20:28Speaker 2: history of the company, because you mentioned earlier Bendum isn't
- 20:32Speaker 2: exactly a startup. I mean, the company's been around for
- 20:34Speaker 2: over ten years, right, and it was founded by you know,
- 20:38Speaker 2: PhD scientists, microbiologists who were interested in studying this connection
- 20:46Speaker 2: between the microbiome and health. They began to study some
- 20:50Speaker 2: of these again quote next generation probiotics as I mentioned earlier,
- 20:56Speaker 2: primarily anaerobic strains, trains that cannot be exposed to oxygen
- 21:01Speaker 2: and that have very profound effects on our health in
- 21:04Speaker 2: particular metabolism, but other aspects of our health. They focus
- 21:10Speaker 2: down on five main strains, and you know, the big
- 21:14Speaker 2: strain being something called acromancia, which I can talk about
- 21:17Speaker 2: more in a moment in terms of the science behind acromancia.
- 21:20Speaker 1: Right.
- 21:21Speaker 2: They once they figured out that these strains were not
- 21:25Speaker 2: only critical for human health, but they wanted to try
- 21:27Speaker 2: to provide access to a product to consumers. They had
- 21:31Speaker 2: to figure out how to grow these anaerobic bacteria in
- 21:36Speaker 2: a way that they would survive. That took about three
- 21:39Speaker 2: years to figure out. And then to your point, they
- 21:43Speaker 2: needed to figure out how to deliver these bacteria to
- 21:47Speaker 2: the distal intestine, to the large intestine the colon basically
- 21:51Speaker 2: the distal pant of your GI track, because that's where
- 21:54Speaker 2: these anaerobic bacteria live in the colon where there isn't oxygen, right,
- 22:00Speaker 2: and so they work through this manufacturing process. Actually built
- 22:07Speaker 2: a plant in San Francisco to manufacture the products and
- 22:13Speaker 2: also utilize this vegetable based, acid resistant delayed release capsule
- 22:22Speaker 2: to allow the bacteria to make it through, as you've
- 22:26Speaker 2: already said, make it through that acidic environment of the
- 22:29Speaker 2: stomach and get all the way down to the to
- 22:32Speaker 2: the large intestine where they get released and kind of
- 22:35Speaker 2: work their magic. Mh.
- 22:37Speaker 1: And what about the methylaids, flow methylators and the and
- 22:41Speaker 1: the toxic people. How how do you get around that?
- 22:44Speaker 2: Yeah, well, I wouldn't use the expression get around it,
- 22:49Speaker 2: because you know, it's it's it really is a part
- 22:52Speaker 2: of an overall approach. You know, I wouldn't say that
- 22:57Speaker 2: you can take almost any pill and just ignore all
- 22:59Speaker 2: the their aspects of lifestyle and expect that you're going
- 23:02Speaker 2: to get the results that you need. So very often,
- 23:04Speaker 2: if someone is you know, dealing with at least in
- 23:07Speaker 2: my clinical practice, if they are kind of quote unquote
- 23:10Speaker 2: toxic as you're describing, or may have issues with methylation,
- 23:13Speaker 2: it's really a comprehensive plan. And I'm often starting by
- 23:15Speaker 2: looking at diet and what we need to do to
- 23:18Speaker 2: enhance their diet and lifestyle overall, and then looking at
- 23:23Speaker 2: how we may integrate appropriate probiotics as a piece of
- 23:26Speaker 2: that overall plan. And so you know, I'd never say
- 23:29Speaker 2: just take a pill and everything's going to get better.
- 23:31Speaker 2: But for many people it's a missing piece because they
- 23:35Speaker 2: haven't thought that the gut microbiome may be a key
- 23:38Speaker 2: component of what they're dealing with.
- 23:41Speaker 1: Absolutely, So let's talk about the specifics. If people who
- 23:46Speaker 1: are watching today have never heard of acamancia and that's
- 23:50Speaker 1: your flagship product, let's take a deep dive and tell
- 23:55Speaker 1: us as if we're kindergarten level, tell us what mancia
- 24:00Speaker 1: is and what it does and how it's going to
- 24:03Speaker 1: improve our overall health.
- 24:05Speaker 2: Sure, I'd love to so we can say different ways.
- 24:08Speaker 2: I say acromancia, but you know I've heard I've heard
- 24:12Speaker 2: people say akromancia. The full name for the strain that
- 24:15Speaker 2: we have is acromancia, muse and ophelia, So which really
- 24:18Speaker 2: needs kind of muse and loving. So I'll talk about that.
- 24:20Speaker 2: There are two main roles that acromancia plays, many many roles,
- 24:25Speaker 2: but two main roles. Maybe that I'll focus on I mean,
- 24:27Speaker 2: because you know there's roles within aging all kinds of
- 24:31Speaker 2: things that that and and influences on the immune system.
- 24:34Speaker 2: But just for the moment, let me focus on two
- 24:38Speaker 2: and and that is the influence on metabolic health and
- 24:42Speaker 2: specifically the release of a hormone that many of your
- 24:45Speaker 2: listeners are probably familiar with called GLP one, which many
- 24:49Speaker 2: people are injecting into themselves to help with weight loss
- 24:51Speaker 2: and diabetes. And so there's the metabolic side, and then
- 24:56Speaker 2: there's this role in helping demain the integrity the health
- 25:01Speaker 2: of the lining of the gut. So first on the
- 25:04Speaker 2: metabolic side, the GLP one side. So it turns out
- 25:10Speaker 2: that when we eat a meal, specific strains of bacteria
- 25:17Speaker 2: in our gut, in this case acromancia, eat that meal.
- 25:22Speaker 2: They eat the fiber within that meal and they release
- 25:27Speaker 2: signaling molecules, and those molecules then tell cells within the
- 25:32Speaker 2: lining of the gut to release this unhunger hormone, GLP one.
- 25:39Speaker 2: And GLP one gets released into the blood, it goes
- 25:43Speaker 2: to the pancreas and it tells the pancreas this person
- 25:47Speaker 2: just ate release insulin so their blood sugar doesn't go
- 25:51Speaker 2: too high. It goes to their gut and slows down
- 25:56Speaker 2: digestions so that you can absorb the foods that you're
- 25:58Speaker 2: eating and feel a little more full, and it travels
- 26:01Speaker 2: up to the brain, to the hippocampus and says, okay,
- 26:06Speaker 2: let's stop this person from eating. Let them feel hungry.
- 26:09Speaker 2: Kind of like when you go to the gas station
- 26:12Speaker 2: to fill up your gas tank if you don't drive
- 26:14Speaker 2: an ev you know, you go to plug it in
- 26:17Speaker 2: and you click the little thing and you can hands free,
- 26:20Speaker 2: and somehow magically that gas pump knows when your tank
- 26:25Speaker 2: is full and it clicks off. And one is really
- 26:28Speaker 2: the hormone that, amongst others, it kind of tells you
- 26:31Speaker 2: to stop eating because you're full. All of that happens
- 26:36Speaker 2: with Acromancia, amongst other strains, as the middleman okay, signaling
- 26:43Speaker 2: the body to make golp one because someone has just
- 26:46Speaker 2: eating a meal. So it's a very important bacteria as
- 26:50Speaker 2: it relates to maintaining a healthy weight, as it may
- 26:53Speaker 2: as it relates to maintaining cravings, as it relates and
- 26:57Speaker 2: not having a problem with cravings. It's very important as
- 27:01Speaker 2: it relates to sort of energy metabolism and utilizing foods
- 27:05Speaker 2: and turning them into energy appropriately without things like your
- 27:08Speaker 2: sugar going too high. So that's one very important component,
- 27:13Speaker 2: and the other really is to maintain this health of
- 27:15Speaker 2: the gut lining. And so let me make sure I
- 27:20Speaker 2: can explain this, you know, for your audience. If we
- 27:22Speaker 2: think of the gut as and maybe describe it the
- 27:27Speaker 2: way our CEO at Pendulum, Colleen likes to describe it
- 27:31Speaker 2: as sort of a fence similar to what she has
- 27:33Speaker 2: in her backyard. If we can imagine the boards sort
- 27:36Speaker 2: of line up, and you want those boards tiped together
- 27:40Speaker 2: so things can't get through. Now, in the case of
- 27:42Speaker 2: our gut, there are mechanisms that allow things that should
- 27:45Speaker 2: get through to get through, but you want to keep
- 27:47Speaker 2: out the things that shouldn't, you know, And then you
- 27:50Speaker 2: want to let in only the thing you know, keep
- 27:52Speaker 2: out foe and let in friend. And so we want
- 27:56Speaker 2: those boards tiped together. But also on the outside side
- 28:00Speaker 2: of that fence, there's sort of a shellac and in
- 28:03Speaker 2: the case of our gut that sheillac is called musin.
- 28:09Speaker 2: It acts kind of like a flypaper. So it also
- 28:12Speaker 2: helps to trap things that maybe you know, trying to
- 28:15Speaker 2: get into our bloodstream. They're going to trigger our immune
- 28:17Speaker 2: system trigger inflammation. And one of the things that acromancia
- 28:23Speaker 2: musin ophelia musein loving acromancia does is almost like a
- 28:27Speaker 2: pac man. It sort of eats up old musin and
- 28:31Speaker 2: stimulates other cells in the gut to actually make new
- 28:35Speaker 2: musein fresh muse and so you keep that gut lining healthy.
- 28:41Speaker 2: And that is so important for so many aspects of
- 28:44Speaker 2: our health, including aging. Because you've probably talked about this
- 28:48Speaker 2: on your podcast, but this concept of inflammaging and how
- 28:52Speaker 2: certain components of aging are really related to certainly our
- 28:54Speaker 2: immune system and an upregulation of inflammation and chronic inflammation.
- 28:59Speaker 2: And when the gut is leaky or if I want
- 29:02Speaker 2: to sound more like a doctor, increase, we have increased
- 29:05Speaker 2: intestinal permeability. But most people know that as leaky gut
- 29:10Speaker 2: that typically is going to contribute to this upregulation of
- 29:13Speaker 2: the of the immune system, upregulation of inflammation, which can
- 29:18Speaker 2: contribute to development of all kinds of diseases and certainly
- 29:21Speaker 2: further the kind of unhealthy aging process that we want
- 29:25Speaker 2: to try to avoid.
- 29:26Speaker 1: And where does LPs come in?
- 29:30Speaker 2: Yeah, so LPs lipopolysaccharides, those are one of the types
- 29:36Speaker 2: of molecules let's say that can leak into the gut
- 29:40Speaker 2: in large amounts when that integrity, that health of that
- 29:45Speaker 2: gut lining isn't what it should be. So when the
- 29:48Speaker 2: LPs is get into the bloodstream, the immune system comes
- 29:51Speaker 2: over and says, what's this? This isn't supposed to be here.
- 29:55Speaker 2: That trigger is sort of a turning on and upregulation
- 29:59Speaker 2: of the immune system, a release of immune cells, which
- 30:02Speaker 2: by and large are pro inflammatory cells. So when we're
- 30:06Speaker 2: leaking a lot of LPs is into the bloodstream, we
- 30:10Speaker 2: are potentially chronically upregulating the immune system and by extension inflammation.
- 30:17Speaker 1: So how did a person who suspects that they may
- 30:22Speaker 1: have leaki gut or some other microbione condition negative condition,
- 30:28Speaker 1: how did they get the best testing to know exactly
- 30:32Speaker 1: what's going on.
- 30:34Speaker 2: Yeah, I mean that's a tricky question, and certainly as
- 30:39Speaker 2: it relates to our microbiome. There are a number of
- 30:42Speaker 2: labs out there that offer testing. The science can vary
- 30:46Speaker 2: a little bit in terms of how they actually do
- 30:50Speaker 2: that testing, but they look often at the microbiome itself.
- 30:54Speaker 2: They look at sort of stool chemistry. So you know,
- 30:58Speaker 2: we're talking about things you might find in someone's poop,
- 31:02Speaker 2: so to speak, but that may give a sign as
- 31:04Speaker 2: to whether or not there are some issues going on.
- 31:08Speaker 2: There's a lot of information that we get from those tests,
- 31:11Speaker 2: and some of that information can be very actionable, and
- 31:14Speaker 2: sometimes we're not quite sure what to do that information
- 31:17Speaker 2: because it's only a snapshot in time. We don't really
- 31:21Speaker 2: know what a healthy microbiome is for you exactly compared
- 31:25Speaker 2: to me. There's a lot of variability around that you
- 31:28Speaker 2: know who, and but often it can give you information
- 31:31Speaker 2: that can be helpful. There are some tests out there
- 31:34Speaker 2: for leaki gut. I will say that the science behind
- 31:38Speaker 2: many of those tests is not rock silent solid, and
- 31:42Speaker 2: we do need to sort of strengthen our understanding of
- 31:45Speaker 2: how we can test for leaki gut. At Mayo Clinic,
- 31:50Speaker 2: they actually have a scope, however, that they use only
- 31:52Speaker 2: for research purposes, and that scope can actually see increased
- 31:57Speaker 2: intestinal permeability in real time. So that certainly is a way,
- 32:00Speaker 2: but it's not, you know, clinically available, but it is
- 32:03Speaker 2: something that I often mentioned because I think there are
- 32:06Speaker 2: still people out there, maybe even healthcare providers out there,
- 32:09Speaker 2: that think, you know, leaki gut doesn't exist, and it
- 32:12Speaker 2: certainly does, and it's well understood and there are you know,
- 32:15Speaker 2: probably thousands of articles out there now describing this concept
- 32:19Speaker 2: of increased intestinal permeability and other medical word endotoxemia really
- 32:24Speaker 2: a fancy medical word for leaking toxins from the gut
- 32:28Speaker 2: into the bloodstream. And and you know that's these are
- 32:31Speaker 2: all different ways of talking about, you know, this concept
- 32:35Speaker 2: of leaky gut and my clinical practice, I'll just say
- 32:38Speaker 2: that I typically assume it's there. You know, it's kind
- 32:40Speaker 2: of when the symptoms are there, and you know, you
- 32:43Speaker 2: kind of assume that they're probably as a component of
- 32:45Speaker 2: leaki gut going on. Because it is hard to test and.
- 32:48Speaker 1: So many people are averse to doing a stool test.
- 32:51Speaker 1: So I was just wondering if there's been any science
- 32:53Speaker 1: and any technology that has advanced from having to go
- 32:59Speaker 1: through the stool tests to getting as efficacious results using
- 33:05Speaker 1: the blood or like KBMO. I don't know if you
- 33:08Speaker 1: know them, doctor James White. He's actually right there where
- 33:13Speaker 1: you and I grew up in the Boston area. But
- 33:16Speaker 1: they it's kb m O and James White is the CEO.
- 33:21Speaker 1: But they do a prick of the finger and they
- 33:23Speaker 1: then give you after a week or so, they send
- 33:26Speaker 1: you the test results, can that possibly? And I don't
- 33:29Speaker 1: want to, you know, demean them in any way, But
- 33:32Speaker 1: I think a lot of people like you, who are
- 33:35Speaker 1: so immersed in this would question whether you can really
- 33:38Speaker 1: get the same kind of knowledge and information from doing
- 33:45Speaker 1: that as you do from a school test. I'm just
- 33:48Speaker 1: curious to know what your thoughts are.
- 33:50Speaker 2: Well, in a general sense, the technology is certainly advancing,
- 33:57Speaker 2: and it's very exciting. Again, you know, without taking a
- 34:00Speaker 2: deep dive. I've heard of KBMO, but without taking a
- 34:03Speaker 2: deep dive in there science. I don't want to comment
- 34:05Speaker 2: one way or another just because I don't know enough
- 34:08Speaker 2: specifically about their science.
- 34:09Speaker 1: Yeah, I wasn't about them about the concept of using
- 34:14Speaker 1: blood versus the stool.
- 34:16Speaker 2: I mean, I would imagine in the long run there
- 34:18Speaker 2: are things we'll be able to tell from the blood.
- 34:22Speaker 2: I don't think the science is close as far as
- 34:24Speaker 2: I understand, to be able to really characterize the microbiome
- 34:27Speaker 2: from some sort of fingerstick. And and you know, I
- 34:32Speaker 2: think it's it behooves us all to keep our our
- 34:37Speaker 2: eye on on the science and how it's advancing. But
- 34:40Speaker 2: I think that it's also important to really allow the
- 34:43Speaker 2: science to be truly validated before we start to use
- 34:46Speaker 2: it to make important healthcare decisions.
- 34:49Speaker 1: And you you know, you're you've been doing this for
- 34:51Speaker 1: a long time, so you've seen that advancement. But I
- 34:55Speaker 1: don't totally agree with you that sometimes you get these
- 34:58Speaker 1: let's just say you take a stool to and you
- 35:00Speaker 1: get all these results that could really complicate because there's
- 35:04Speaker 1: so much information that you might miss the you know,
- 35:08Speaker 1: the bullseye in terms of what is really the cause,
- 35:11Speaker 1: instead of having all these potential influences that aren't really
- 35:16Speaker 1: making that that huge difference. But the information is so
- 35:21Speaker 1: voluminous that you can you know, misread. I guess it's
- 35:24Speaker 1: just like getting false positives and well, you know I'm
- 35:29Speaker 1: saying and like what I'm not I'm not asking you
- 35:33Speaker 1: to comment on that because it's obviously a truth, and
- 35:37Speaker 1: it just it's gonna, you know, it's good. It's going
- 35:39Speaker 1: to exist for a while until there's some easy way
- 35:42Speaker 1: for us to get the information with without all the
- 35:45Speaker 1: confusion of the potential confusion. But then what about Candida
- 35:50Speaker 1: and and you know a yeast infections which so many
- 35:53Speaker 1: people complain, you know, they've gotten one strain or another.
- 35:58Speaker 1: There's I think there's three strains, right of candida possibility
- 36:01Speaker 1: like the AID.
- 36:03Speaker 2: Yeah, there are multiple strains, and I think you know,
- 36:06Speaker 2: there's another example where most of the stool testing can
- 36:09Speaker 2: certainly see if there are elevated levels and there are treatments.
- 36:16Speaker 2: Very often though for a practice like mine, if we're
- 36:18Speaker 2: concerned about those sorts of issues or candida specifically, we
- 36:22Speaker 2: try to start with adjusting diet and looking at the
- 36:25Speaker 2: microbiome potentially, or thinking about the microbiome and where there
- 36:29Speaker 2: may be imbalances and how we might help to restore
- 36:34Speaker 2: a balance to that ecosystem. So that's always an important consideration.
- 36:39Speaker 1: Yeah, so that diet would obviously the first and foremost
- 36:43Speaker 1: is get rid of sugar, right, I think that goes
- 36:47Speaker 1: for all of what we're talking about, that sugar is
- 36:49Speaker 1: the big enemy of the health of the microbiome and
- 36:53Speaker 1: the health of the person overall. And then process food,
- 36:58Speaker 1: which is the sad diet standard American diet, which you know,
- 37:03Speaker 1: fortunately you and I are lucky enough to have known
- 37:06Speaker 1: a long time ago to you know, not shop in
- 37:08Speaker 1: the middle of the grocery store, to always only go
- 37:12Speaker 1: to the aisles and where the you know, the protein
- 37:16Speaker 1: and the and the vegetables and fruit are and I
- 37:18Speaker 1: guess in some Candida diets you're not supposed to eat
- 37:21Speaker 1: certain fruits because they're heavy in sugar, like bananas, I
- 37:23Speaker 1: guess would be one. But anyway, before we get into nutrition,
- 37:29Speaker 1: which I do want you to talk about a little bit,
- 37:31Speaker 1: when but I had a couple other questions. I don't
- 37:33Speaker 1: want to lose the acamancia and the but rate and
- 37:38Speaker 1: then the tribe uterate because I was reading about that
- 37:41Speaker 1: and I didn't know the difference. What is the difference
- 37:44Speaker 1: between but ate and tribeuterate.
- 37:47Speaker 2: Well, so let me again maybe step back and say
- 37:52Speaker 2: that if we think about this from the perspective of
- 37:59Speaker 2: the five strain that let's say Pendulum has brought to
- 38:01Speaker 2: the market, right, And so the first product that Pendulum
- 38:05Speaker 2: released was called Pendulum Glucose Control. And what's interesting about
- 38:10Speaker 2: that is it has I'm.
- 38:11Speaker 1: Sorry that was the study that you worked on.
- 38:14Speaker 2: I didn't, that's correct, the follow up study. So there
- 38:16Speaker 2: was an original study that was published in the British
- 38:19Speaker 2: Meta and the BMJ, which medical journal, and that was
- 38:25Speaker 2: a clinical trial, randomized clinical trial that looked at the
- 38:30Speaker 2: use of this five strained formulation and people with type
- 38:34Speaker 2: two diabetes, so we're actually on treatments like met forman,
- 38:37Speaker 2: and showed that in individuals with clear signs of metabolic dysfunction,
- 38:41Speaker 2: including in this case type two diabetes, that there were
- 38:46Speaker 2: clinically significant, statistically and clinic significant improvements in glucose control.
- 38:51Speaker 2: So glucose spikes is something we measure on continuous glucose monitors.
- 38:56Speaker 2: Decreased by thirty three percent. And then again any of
- 39:00Speaker 2: your audience that is familiar with diabetes will know one
- 39:03Speaker 2: of the main things we monitor is something called hemoglobin
- 39:06Speaker 2: A one c. It's just a blood test that we
- 39:08Speaker 2: monitor for diabetes control. And it was actually a zero
- 39:13Speaker 2: point six improvement in hemoglobin A one c and diabetics.
- 39:18Speaker 2: And so that's what the gl pendulum glucose control products.
- 39:21Speaker 2: So that product has five strains. It has acromancia, and
- 39:26Speaker 2: then it's got three primary butyrate producers, and I could
- 39:29Speaker 2: list them all off for you, but the three different
- 39:31Speaker 2: sort of clastridium trains strains Bricum putriichii, Anerobuterricum hallei, these
- 39:37Speaker 2: all make short chain fatty acids. Butyrate is a short
- 39:41Speaker 2: chain fatty acid. Don't want to get too technical here,
- 39:44Speaker 2: but and then there's a fifth strain which is called
- 39:48Speaker 2: bafido Bacterium infantis, which the pediatricians know a lot about.
- 39:52Speaker 2: It's very important in those first few years of life,
- 39:55Speaker 2: but it continues to maintain a role later in life,
- 39:58Speaker 2: and that's what's often referred to as a primary fermenttor.
- 40:02Speaker 2: So it sort of helps to support other bacterial strains.
- 40:06Speaker 2: The way bacterial work is, you know, it's kind of
- 40:10Speaker 2: like a city. You know, everyone has different jobs and
- 40:14Speaker 2: there's some overlap, so you know, I don't know, maybe
- 40:17Speaker 2: the example might be the police. I mean you might
- 40:19Speaker 2: have a sheriff's office, you might have the state police.
- 40:22Speaker 2: There's the FBI. You know, there's not just one division
- 40:25Speaker 2: that deals with legal, so you know there's an overlap there.
- 40:28Speaker 2: And it's the same thing with the gut. There's an
- 40:30Speaker 2: overlap of effort. There's also bad players, just like you
- 40:33Speaker 2: might find in any city or any community, and you know,
- 40:37Speaker 2: everyone's trying to keep each other in check. And so
- 40:40Speaker 2: these five strains really work synergistically. But you know, to
- 40:45Speaker 2: your point with beer it being so important and the
- 40:49Speaker 2: way they work together, what the company was able to
- 40:52Speaker 2: do was sort of through through our researches, is to
- 40:56Speaker 2: put together a three strain formulation. So that's the newest train,
- 41:00Speaker 2: the newest product that we've brought to market, which is
- 41:02Speaker 2: called GLP one probiotic that specifically as acromancia. It has
- 41:08Speaker 2: the Clustridium butterricum and it has the baffido Bacterium infantis
- 41:14Speaker 2: mm hm. Those three strains again work synergistically, they work together. Interestingly,
- 41:20Speaker 2: we actually studied that formulation and showed this significant decrease
- 41:25Speaker 2: in cravings, which was really really instant. I can talk
- 41:28Speaker 2: about that research, you know, certainly in a moment, but
- 41:31Speaker 2: really interesting stuff there.
- 41:33Speaker 1: Well, so I am going to ask you about the
- 41:37Speaker 1: decrease in cravings, but I also wanted to mention the
- 41:41Speaker 1: polyphenos and how important they are also synergistic with the
- 41:48Speaker 1: impact of the achamanc acromencia. At some point I'm going
- 41:52Speaker 1: to say it right, but you know, the point is
- 41:55Speaker 1: with most people don't understand that golp one that they're
- 42:01Speaker 1: injecting to lose, relate, or control metabholic health is synthetic
- 42:08Speaker 1: and there are side effects and there many have been reported,
- 42:12Speaker 1: whereas your product is completely natural and will not produce
- 42:17Speaker 1: the side effects that have been associated with the injections
- 42:22Speaker 1: of GLP one. Am I correct on.
- 42:25Speaker 2: That this goes back to what I was saying really
- 42:28Speaker 2: at the beginning of our conversation today, and this interest
- 42:33Speaker 2: in how do we work at the level of the
- 42:35Speaker 2: biological system, how do we you know, how do we
- 42:38Speaker 2: work to help those biological systems to work the way
- 42:42Speaker 2: they're supposed to. And so, yes, you can inject synthetic
- 42:45Speaker 2: GLP one, it's not the way the body naturally utilizes
- 42:51Speaker 2: GLP one, you know, just this injection periodically. What the
- 42:54Speaker 2: body does, as I've already explained, is really released GLP
- 42:57Speaker 2: one as it should in responds to a meal. But
- 43:01Speaker 2: there are so many things that people could do inadvertently
- 43:05Speaker 2: or on purpose without recognizing that they are having a
- 43:08Speaker 2: negative effect on their microbiome, from a poor diet of course,
- 43:12Speaker 2: to medications that they may or may not need to take,
- 43:15Speaker 2: to stress, to things that you don't have control over,
- 43:19Speaker 2: like whether you're pre oppostmenopausal, or you know, if you've
- 43:22Speaker 2: just traveled through a few time zones and there's a
- 43:24Speaker 2: change in your influence on your circadian rhythms. All of
- 43:28Speaker 2: this can have traumatic brain injuries. All of this can
- 43:30Speaker 2: have an influence on our gut health. So it's not
- 43:32Speaker 2: unusual that we don't have the right mix of bacteria
- 43:36Speaker 2: and therefore that biological system isn't working the way that
- 43:40Speaker 2: it should. And what we're doing when we're giving these
- 43:43Speaker 2: specific strains of probiotics is really working at that level
- 43:47Speaker 2: of the biological system to get it to function the
- 43:50Speaker 2: way it should so that your cravings don't spike, so
- 43:53Speaker 2: that you're able to manage your blood sugar, you're able
- 43:55Speaker 2: to sort of manage your energy levels better and metabolize
- 43:58Speaker 2: things the way that you should. And you mentioned polyphenols,
- 44:01Speaker 2: so I mean I can just transition to Pendulum actually
- 44:04Speaker 2: has five products that they have pendulum glucose control, they
- 44:10Speaker 2: have some pendulum metabolic daily that really is sort of
- 44:13Speaker 2: a good daily one to take. I like that people
- 44:15Speaker 2: are really trying to manage their energy levels and energy
- 44:18Speaker 2: metabolism and you sort of their metabolism rather the GLP
- 44:22Speaker 2: one probiotic that I just mentioned that we've really studied.
- 44:26Speaker 2: We're doing a large clinical trial now, but in the
- 44:29Speaker 2: early work that we did with consumers, that's the one
- 44:32Speaker 2: with cravings that I can talk about in a moment.
- 44:35Speaker 2: You can certainly purchase acromancia by itself. Then we do
- 44:39Speaker 2: have the polyphenol product. And what we did there is
- 44:44Speaker 2: is we were intersted in providing products that would support
- 44:48Speaker 2: not only probiotics, but the specific strains of probiotic you
- 44:51Speaker 2: know that we're discussing today, and that obviously within the
- 44:53Speaker 2: pendulum products. And so we actually studied what type of
- 44:57Speaker 2: polyphenols a most effective supportive and it turns out that
- 45:03Speaker 2: they're polyphenols from pomegranate, green tea, and grape seed. So
- 45:07Speaker 2: that's the fifth product. Is this polyphenol product that you know,
- 45:11Speaker 2: someone says to me, well, what can I do to
- 45:13Speaker 2: help the efficacy of these products? I certainly say, you know,
- 45:16Speaker 2: eat a healthy diet, plenty of fiber polyphenols through your diet.
- 45:20Speaker 2: But it can be difficult for people we're traveling, we
- 45:23Speaker 2: may not always have access to enough fruits and vegetables.
- 45:26Speaker 2: I mean, polyphenols are often the things that give our
- 45:29Speaker 2: vegetables and fruits color, and you know, sometimes it can
- 45:33Speaker 2: be tough to eat a rainbow.
- 45:35Speaker 1: Right.
- 45:36Speaker 2: When that's the case, we can always supplement with the
- 45:39Speaker 2: polyphenols and support the efficacy of these bacteria I take.
- 45:44Speaker 1: I just full transparency that good old Atom sent me
- 45:49Speaker 1: to try the two products. So he just mentioned the
- 45:52Speaker 1: GLP one and the polyphenols, and I take them together.
- 45:55Speaker 1: You know, at the beginning, Atom, I didn't know. I
- 45:58Speaker 1: always thought you're supposed to pick probiotics on an empty stomach,
- 46:01Speaker 1: and then I listened to you, and I guess I
- 46:04Speaker 1: didn't read it on the bottle or something. But now
- 46:06Speaker 1: I only take them with food, and usually because I
- 46:10Speaker 1: don't eat until my first meal is usually like you,
- 46:12Speaker 1: around eleven am, so I usually take them back with
- 46:16Speaker 1: my first meal now, But gosh, for the first two
- 46:19Speaker 1: weeks that I had them, I was taking them right
- 46:21Speaker 1: away when I woke up with my empty stomach. Vitamins,
- 46:25Speaker 1: So was I ever getting any efficacy on those when
- 46:29Speaker 1: I took them on an empty stomach?
- 46:31Speaker 2: Oh, you certainly were. Again, as I explained earlier, they
- 46:33Speaker 2: are in this vegetarian acid resistant delayed release capsule.
- 46:39Speaker 1: Yeah, and tear it.
- 46:40Speaker 2: However, you know, like many of our pills, and certainly
- 46:44Speaker 2: many of the vitamins that people take, when you do
- 46:47Speaker 2: take them with food, there's some additional benefit in terms
- 46:51Speaker 2: of helping to get through the stomach and that kind
- 46:53Speaker 2: of of a thing. So I get asked this all
- 46:57Speaker 2: the time. Just the other day, literally yesterday, someone said, well,
- 47:01Speaker 2: what's the best time to take them? And do I
- 47:03Speaker 2: need to take them with food? And I said, it's
- 47:04Speaker 2: better to take them with food, But the best time
- 47:07Speaker 2: to take them is the time you're going to remember
- 47:08Speaker 2: to take them, you know, And so don't, right, it's
- 47:12Speaker 2: better to take them without.
- 47:13Speaker 1: I cannot forget because they are so vital to everything
- 47:17Speaker 1: else you do. They're like the foundation, just like the
- 47:21Speaker 1: you know, when we're talking about the health of the
- 47:23Speaker 1: whole body. The microbione is the foundational influence to everything
- 47:29Speaker 1: else that you're going to build on. So it's like
- 47:32Speaker 1: I'm at real estate developer. I always you know, look
- 47:35Speaker 1: at metaphors and to me, they're like, you know, the
- 47:39Speaker 1: concrete of the foundation of a home that you're starting
- 47:42Speaker 1: to build. And so yeah, it's just impossible to forget
- 47:46Speaker 1: something that's that important. You couldn't build a house without
- 47:48Speaker 1: a foundation. So you'd be throwing away all the other
- 47:52Speaker 1: products that you're using if you don't get to the
- 47:55Speaker 1: healthy microbiome first. And I guess the other question I
- 48:00Speaker 1: was wondering about it. I mean I have for you
- 48:02Speaker 1: is how do you know when your microbiome is working
- 48:08Speaker 1: perfectly well?
- 48:13Speaker 2: I might have to turn that question around a little bit,
- 48:16Speaker 2: right because I would say, if you're feeling good and
- 48:18Speaker 2: your metabolic health is good and overall the other things
- 48:23Speaker 2: that we look at within health and prevention of diseases
- 48:27Speaker 2: is seems to be in the right place, one might
- 48:30Speaker 2: make an assumption that, amongst other things you're doing right,
- 48:33Speaker 2: your microbiome is being fed properly and probably in pretty
- 48:36Speaker 2: good shape. That doesn't mean that we don't sometimes want
- 48:39Speaker 2: to supplement just to make sure that we help to
- 48:41Speaker 2: maintain that health. And that's in this case the health
- 48:44Speaker 2: of the microbiome. But it's really the other way around,
- 48:47Speaker 2: which is how might we suspect there's an issue with
- 48:50Speaker 2: our microbiome? And again that's when I go back to
- 48:53Speaker 2: are you having issues with metabolic health? Is your sugar
- 48:56Speaker 2: is running a little bit high? Are you having issues
- 48:58Speaker 2: with craving, You're having fatigue, brain fog, all kinds of issues.
- 49:03Speaker 2: Now we're starting to understand the gut brain connection, you know,
- 49:06Speaker 2: and how the microbiome is influencing things like how we're
- 49:10Speaker 2: feeling emotionally, Are we feeling somewhat depressed, are we feeling anxious?
- 49:15Speaker 2: Those are the kind of symptoms and conditions that may
- 49:18Speaker 2: indicate that part of the issue may exist within that microbiome.
- 49:22Speaker 2: And again, things like the microbiome makes ninety percent of
- 49:26Speaker 2: the serotonin or the gut make pardon me, the gut, rather,
- 49:29Speaker 2: it makes ninety percent of the serotonin for the body,
- 49:33Speaker 2: this important neurotransmitter that influences how we feel emotionally. Many
- 49:37Speaker 2: people don't realize that, and so when there's disruptions of
- 49:40Speaker 2: the gut, when there's disruptions of the microbiome specifically, it
- 49:44Speaker 2: can influence how we're feeling physically, it can influence how
- 49:47Speaker 2: we're feeling emotionally, and certainly can influence our physiologic health.
- 49:51Speaker 2: You know, things like our glucose and other aspects, even
- 49:57Speaker 2: your blood pressure without a debat, so blood pressure is
- 50:00Speaker 2: a part of that whole metabolic health. You know, scenario, cholesterol, triglycerides,
- 50:06Speaker 2: you know, these sorts of things all are part of
- 50:09Speaker 2: the concept of metabolic health and trying to be healthy
- 50:12Speaker 2: from a metabolic perspective. And the problem is that I
- 50:16Speaker 2: think it's one in three adults have you know, metabolic
- 50:19Speaker 2: dysfunction metabolic syndrome, and it's upwards of eighty eight to
- 50:23Speaker 2: ninety percent of Americans have some sign of metabolic dysfunction.
- 50:28Speaker 2: And why because look around right by and large, you know,
- 50:34Speaker 2: we're not eating what we should be eating. And even
- 50:37Speaker 2: if we are trying to eat right, there's other things
- 50:39Speaker 2: we may be get exposed to, toxins, et cetera. And so
- 50:42Speaker 2: it's difficult. It's difficult to live that pristine life in
- 50:47Speaker 2: our current sort of environment. And we all should do
- 50:50Speaker 2: what we can to maintain our health and maintain the
- 50:54Speaker 2: health of our microbiome. And certainly the pillars are eating
- 50:58Speaker 2: right and exercising and managing dress and getting sleep and
- 51:01Speaker 2: having healthy relationships. But because there's so many factors that
- 51:07Speaker 2: are make it difficult for us, you know, to make
- 51:10Speaker 2: all the right choices and not get exposed to things
- 51:13Speaker 2: which are in the environment many of us, it is
- 51:16Speaker 2: important that we also supplement in this case right probiotics.
- 51:20Speaker 2: If we're concerned about microbiome health and metabolic health and
- 51:24Speaker 2: cravings and the things that we've been discussing.
- 51:26Speaker 1: So before we get into the cravings, I just wanted
- 51:29Speaker 1: to say that I did have doctor Elizabeth Urs, who's
- 51:33Speaker 1: a Bolder Longevity Institute doctor, very very well, highly regarded
- 51:39Speaker 1: and just you know, an amazing human being. So she
- 51:44Speaker 1: said that what she does is she micro goeses with
- 51:49Speaker 1: VLP one agonist with the injection. She's an athlete and
- 51:55Speaker 1: she's always you know, obviously looking to manage her metabolic
- 52:00Speaker 1: health and her athletic health as a result of course,
- 52:03Speaker 1: and and her weight, which is you know who everybody
- 52:07Speaker 1: seems to be concerned about that because there's so many
- 52:10Speaker 1: there's so many temptations in our environment, and you know,
- 52:14Speaker 1: people who are really disciplined like we are, we still
- 52:17Speaker 1: have those moments and that's where these cravings come in,
- 52:20Speaker 1: which we'll talk about in a second. But anyway, so
- 52:24Speaker 1: what do you think about microdosing and could you combine
- 52:28Speaker 1: that with your products or is that too much over
- 52:31Speaker 1: the top to use GLP one injections along with the
- 52:35Speaker 1: g LP one probiotic that and the poly females that
- 52:40Speaker 1: the combination that I've been using that you sent me
- 52:43Speaker 1: is that is that something that would make a difference
- 52:46Speaker 1: or is it too much?
- 52:49Speaker 2: So a few comments there. First, want to be very
- 52:51Speaker 2: clear that our products and certainly the g LP one probiotic,
- 52:57Speaker 2: they're not in the same class. They're not medications and
- 52:59Speaker 2: audits same class as these GLP on analog drugs, right,
- 53:02Speaker 2: They're not a replacement for those drugs. So, just to
- 53:04Speaker 2: be very clear, I've certainly heard of the microdosing. I
- 53:08Speaker 2: haven't had any patients that have actually utilized it, so
- 53:12Speaker 2: I don't have much firsthand experience with it. I know
- 53:14Speaker 2: it is something that people are doing. Similarly, we don't
- 53:18Speaker 2: officially recommend or or recommend against taking the probiotics with
- 53:23Speaker 2: the medications or in a microdosing sort of scenario. The
- 53:27Speaker 2: truth is we haven't studied it, and so I always
- 53:30Speaker 2: like to comment from what I understand from the science.
- 53:32Speaker 2: We don't have a lot of science here. What I
- 53:34Speaker 2: can tell you is we're actually in the middle of
- 53:37Speaker 2: an athlete study with one of our products, and so
- 53:40Speaker 2: we are very interested in the use of these probiotics
- 53:43Speaker 2: in athletes, amongst other things. Very often depending on your
- 53:47Speaker 2: degree of exercise. Certainly extremes of exercise like running in
- 53:50Speaker 2: ultra marathons, as I may have mentioned earlier, lead to
- 53:53Speaker 2: things like leaky gout or increased in no taxemia. There
- 53:58Speaker 2: can be mood issues and athletes that can be related.
- 54:01Speaker 2: It's felt disturbances in the gut that is influenced by
- 54:04Speaker 2: certainly significant exercise. And so this whole gut kind of
- 54:09Speaker 2: exercise connection is important and something we're interested in, and
- 54:14Speaker 2: as I've said, we're studying.
- 54:16Speaker 1: Yeah, I'm so glad you brought that up, because, as
- 54:18Speaker 1: I mentioned to you, we're one of our platforms is
- 54:21Speaker 1: Muscle and Fitness and they only in the last two
- 54:25Speaker 1: years has this magazine that's been known for a century.
- 54:30Speaker 1: I mean this is you know, the the Joe Reader
- 54:34Speaker 1: and Arnold Schwarzenegger and that whole, and I think they
- 54:37Speaker 1: have like a billion subscribers to the magazine. However, they
- 54:42Speaker 1: never went digital until two years ago and doctor Bob Goldman,
- 54:46Speaker 1: who's the co founder of the American Academy of Anti Aging,
- 54:51Speaker 1: getting involved with them. And so I was lucky enough
- 54:54Speaker 1: as a podcast host that he had been on my podcast.
- 54:58Speaker 1: I've known him for many years, and he called me
- 55:01Speaker 1: and he said, you know, we're doing only twenty inaugural
- 55:06Speaker 1: podcast on our digital sites, just going live. And this
- 55:10Speaker 1: was I think maybe not even two years a year
- 55:13Speaker 1: and a half ago. So because we have this big
- 55:16Speaker 1: demographic and even psychographic of athletes on ageless and timeless.
- 55:23Speaker 1: I always want to steer a conversation towards what's best
- 55:27Speaker 1: for athletes, and so the fact that you're doing this study,
- 55:31Speaker 1: I really want to know what happens when you're done
- 55:35Speaker 1: with the study, if you wouldn't mind, so I could
- 55:37Speaker 1: then add that to our show notes for this podcast,
- 55:41Speaker 1: or if it's done, you know, next year twenty twenty
- 55:45Speaker 1: five or twenty twenty six, we'll have you back on
- 55:49Speaker 1: to go over that. But this is really really important
- 55:51Speaker 1: stuff that we're you know, really I mean highly interested
- 55:55Speaker 1: in knowing the results of that study. And then also,
- 55:59Speaker 1: you know, muscle loss is such a big issue that
- 56:03Speaker 1: I hear all the time side effects of people who
- 56:05Speaker 1: are using the injectable synthetic form of the mangaro or
- 56:12Speaker 1: ozembic orgov or you know, all these the ones that
- 56:18Speaker 1: are I think there's a new one now called trepenzizide
- 56:22Speaker 1: or something like that that people are saying is the
- 56:25Speaker 1: hottest new one. But all of these are synthetic, and
- 56:28Speaker 1: they're all injectable, and they're all side effects. However, there
- 56:32Speaker 1: are people that have been thrilled with the results and
- 56:36Speaker 1: look at look at Oprah Winfrey as an example, and
- 56:39Speaker 1: that people who have lost so much weight and improve
- 56:44Speaker 1: their diet, you know, their type two diabetes as well.
- 56:47Speaker 1: So I would never, you know, diminish the impact that
- 56:51Speaker 1: they've had. I think they're one of the greatest potential
- 56:55Speaker 1: achievements in modern medicine, that if people do it correctly
- 56:59Speaker 1: and they exercise, because the muscle loss is real. And
- 57:03Speaker 1: in fact, I remember when they first came out. I
- 57:05Speaker 1: called my doctor, who was a functional medicine practitioner, and
- 57:10Speaker 1: I said, oh, I'd love to take this, and you know,
- 57:12Speaker 1: would you allow me? And she said absolutely no. She said,
- 57:15Speaker 1: you're already so muscular, and why would you ever want
- 57:19Speaker 1: to play with that because you do work out, You've
- 57:21Speaker 1: always been an athlete, and don't tamper with what's good
- 57:26Speaker 1: just to lose five pounds because you know, I don't
- 57:28Speaker 1: know too many women that wouldn't want to lose at
- 57:31Speaker 1: least five pounds, and so I put myself in that category.
- 57:34Speaker 1: So anyway, she said absolutely no, And I don't like
- 57:38Speaker 1: I don't take any pharmaceutical drugs anyway, so I, you know,
- 57:42Speaker 1: purist in that regard. But when I heard I think
- 57:46Speaker 1: I told you the story. I was at apho or
- 57:47Speaker 1: Am and Pendulum was one of the exhibitors. I went
- 57:50Speaker 1: up to the booth was mobbed, and when I went
- 57:53Speaker 1: up there and they said, here, here's a bottle of
- 57:57Speaker 1: one of our products. At that time, it was giving
- 58:00Speaker 1: away the Accamensia, just singular bottle. So that's how I
- 58:05Speaker 1: first knew about you. And of course I loved it
- 58:08Speaker 1: that Colleen, when you know the CEO is a woman,
- 58:11Speaker 1: and you know I read her background and I will
- 58:13Speaker 1: have her on it at one point. But so so
- 58:18Speaker 1: long story one ways say that you know there are
- 58:20Speaker 1: side effects, and so happy that you have the GLP
- 58:24Speaker 1: one probiotic combined with the polyphenos which I think is
- 58:28Speaker 1: so much healthier because it's not a you know, just
- 58:31Speaker 1: as you said, it's not a drug. And so I
- 58:34Speaker 1: just want people to know. But before because I just
- 58:37Speaker 1: got flashed, and I know we were going to talk
- 58:39Speaker 1: about the cravings issue. But those products will help you
- 58:44Speaker 1: with cravings. I don't seem to have too many craves.
- 58:46Speaker 1: I do love dark chocolate, which is a good craving.
- 58:50Speaker 1: But I'm not one of those people that you know
- 58:52Speaker 1: has issues with overeating. Out of stress or in fact,
- 58:56Speaker 1: I usually would go the other way. So I feel
- 58:58Speaker 1: really lucky that these products are more too over the
- 59:02Speaker 1: top help and know that they're you know that they're
- 59:06Speaker 1: just going to improve what might already be in very
- 59:09Speaker 1: good shape. But not everybody is in that camp. And
- 59:14Speaker 1: the good thing is that it doesn't affect your muscles
- 59:16Speaker 1: at all, only to help you because you're you know
- 59:19Speaker 1: you're it actually helps when it helps to diminish your
- 59:23Speaker 1: your appetite, it also helps you to increase your energy level.
- 59:29Speaker 2: It.
- 59:29Speaker 1: You know, you would think if you were starving yourself,
- 59:32Speaker 1: like sometimes with intermittent fasting, if you fast too long,
- 59:35Speaker 1: you are getting muscle wasting. But with this product, these
- 59:39Speaker 1: products that you have with pendulum, that doesn't happen. So anyway,
- 59:45Speaker 1: before we have to go, I just want you to
- 59:47Speaker 1: tell us, okay, tell us about the cravings really quickly
- 59:50Speaker 1: and how this will scientifically how you your products affect
- 59:54Speaker 1: the cravings.
- 59:55Speaker 2: Yeah, quickly. Then we did a study with consumers and
- 1:00:01Speaker 2: this was on the GLP one probiotic product, and we
- 1:00:05Speaker 2: measured they started taking the product and we measured their
- 1:00:10Speaker 2: cravings at baseline with this validated questionnaire that looks at
- 1:00:14Speaker 2: cravings and then at six weeks, and what we found
- 1:00:18Speaker 2: was that ninety one percent of people taking the GLP
- 1:00:20Speaker 2: one probiotic had a significant reduction in cravings. Interestingly, if
- 1:00:25Speaker 2: they had higher cravings at baseline, they tended to see
- 1:00:28Speaker 2: a greater reduction. And this questionnaire actually looks at cravings
- 1:00:32Speaker 2: in four different areas, and all of those areas had
- 1:00:34Speaker 2: significant reductions. It was sugars, it was starches, it was
- 1:00:40Speaker 2: high fat foods, and it was high fat fast foods.
- 1:00:43Speaker 2: Actually looks at fast foods as well, and so within
- 1:00:45Speaker 2: every one of those areas there were significant reductions in cravings.
- 1:00:49Speaker 2: So we're now sort of using that info. But as
- 1:00:53Speaker 2: I've said earlier, we're actually doing a much more robust
- 1:00:56Speaker 2: clinical trial and looking at all kinds of outcomes. So
- 1:00:59Speaker 2: as you've said, I mean, not only with the athlete study,
- 1:01:01Speaker 2: but with all of our research. First of all, we
- 1:01:04Speaker 2: intend to publish, but second of all, you know, I'd
- 1:01:07Speaker 2: love to come back on and discuss all those findings.
- 1:01:09Speaker 2: I mean, it's really one of the main reasons I
- 1:01:12Speaker 2: went to the company, beyond I was seeing so much
- 1:01:14Speaker 2: efficacy in my clinical practice, was the commitment to the
- 1:01:17Speaker 2: research because half of my job is doing this, but
- 1:01:20Speaker 2: the other half, or even the majority of it is
- 1:01:23Speaker 2: is overseeing our clinical research. And we have all kinds
- 1:01:26Speaker 2: of studies going on that were supporting and sponsering. So
- 1:01:29Speaker 2: it's exciting, right.
- 1:01:31Speaker 1: Well, if Tony, if our CEO is listening, I hope
- 1:01:35Speaker 1: he'll flash your website on the screen because I did
- 1:01:38Speaker 1: want people to know that you've so generously offered our
- 1:01:42Speaker 1: viewers a twenty percent discount. So you'd have to go
- 1:01:47Speaker 1: to pendulum Life, right, pendulumlife dot dot com and type
- 1:01:53Speaker 1: in ageless. He's already Adam has already set up a
- 1:01:56Speaker 1: code for us, and that's it, right, That's all you
- 1:02:00Speaker 1: have to do is that's your coupon code and you
- 1:02:02Speaker 1: get twenty percent off of your products.
- 1:02:05Speaker 2: They're twenty percent off of I think your first membership
- 1:02:08Speaker 2: board or something like that, but it is twenty percent.
- 1:02:11Speaker 2: And you know, we also have a lot more information
- 1:02:13Speaker 2: on the pendulumlife dot com website. Yeah, a lot of
- 1:02:16Speaker 2: our sciences. There even information on clinical trials that were
- 1:02:19Speaker 2: involved in and some protocols for healthcare providers and others
- 1:02:24Speaker 2: things like that. But if people are interested, they can
- 1:02:27Speaker 2: go to that website and as you've said, use the
- 1:02:30Speaker 2: code ageless and try it for themselves.
- 1:02:34Speaker 1: Well, Adam, I knew that. You know, we could talk
- 1:02:37Speaker 1: forever because we just have that chemistry. And I love
- 1:02:40Speaker 1: the energy between us, and I love that you've been
- 1:02:43Speaker 1: so much of a front runner and in health span
- 1:02:48Speaker 1: and lifespan and knowing so early on in your career
- 1:02:53Speaker 1: when you were really just a med school graduate that
- 1:02:57Speaker 1: you were going to focus on something that was really
- 1:02:59Speaker 1: just urging beginning to burgeon and has now grown into
- 1:03:03Speaker 1: you know, a full on I guess you would call
- 1:03:07Speaker 1: it validated discipline, which is you know, this functional integrative medicine.
- 1:03:12Speaker 1: So thank you so much for being with us today,
- 1:03:15Speaker 1: and I hope you have a wonderful weekend.
- 1:03:18Speaker 2: Oh thank you you as well, and thank you for
- 1:03:20Speaker 2: doing this kind of a podcast. It's so important to
- 1:03:23Speaker 2: get people sort of reliable information that they can use
- 1:03:26Speaker 2: to make their healthcare decisions. So I really appreciate what
- 1:03:28Speaker 2: you're doing and.
- 1:03:29Speaker 1: I couldn't do it without people like you, So I
- 1:03:32Speaker 1: feel very honored. So thank you so much, Adam. Take
- 1:03:35Speaker 1: care you as well. Okay, bye bye